Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53,599,048
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2,785,956
-
Shares change
-
+13,301
-
Total reported value, excl. options
-
$5,517,109
-
Value change
-
+$81,616
-
Put/Call ratio
-
0%
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$1.98
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q4 2022
25 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share as of Q4 2022.
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,785,956 shares
of 53,599,048 outstanding shares and own 5.2% of the company stock.
Largest 10 shareholders include Abingworth LLP (1,201,506 shares), Nantahala Capital Management, LLC (604,179 shares), AIGH Capital Management LLC (422,489 shares), J. Goldman & Co LP (112,499 shares), Worth Venture Partners, LLC (103,913 shares), Clayton Partners LLC (92,772 shares), VANGUARD GROUP INC (49,939 shares), RENAISSANCE TECHNOLOGIES LLC (49,754 shares), MILLENNIUM MANAGEMENT LLC (45,876 shares), and GEODE CAPITAL MANAGEMENT, LLC (32,556 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.